ID: ALA3642241

Max Phase: Preclinical

Molecular Formula: C18H28N2O2

Molecular Weight: 304.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CC(=O)N1CCC(NC(=O)C23CC4CC(CC(C4)C2)C3)CC1

Standard InChI:  InChI=1S/C18H28N2O2/c1-12(21)20-4-2-16(3-5-20)19-17(22)18-9-13-6-14(10-18)8-15(7-13)11-18/h13-16H,2-11H2,1H3,(H,19,22)

Standard InChI Key:  SEIPMGNTIJAMOG-UHFFFAOYSA-N

Associated Targets(Human)

Epoxide hydrolase 1 644 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 304.43Molecular Weight (Monoisotopic): 304.2151AlogP: 2.33#Rotatable Bonds: 2
Polar Surface Area: 49.41Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.99CX LogP: 1.05CX LogD: 1.05
Aromatic Rings: 0Heavy Atoms: 22QED Weighted: 0.85Np Likeness Score: -1.02

References

1.  (2013)  Conformationally restricted urea inhibitors of soluble epoxide hydrolase, 

Source

Source(1):